CZAMX vs. RMDFX
Compare and contrast key facts about Multi-Manager Alternative Strategies Fund (CZAMX) and Aspiriant Defensive Allocation Fund (RMDFX).
CZAMX is managed by Columbia. It was launched on Jan 2, 2017. RMDFX is managed by Aspiriant. It was launched on Dec 13, 2015.
Performance
CZAMX vs. RMDFX - Performance Comparison
Loading graphics...
CZAMX vs. RMDFX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CZAMX Multi-Manager Alternative Strategies Fund | 1.63% | 4.59% | 1.99% | 3.07% | 2.85% | 0.80% | 5.78% | 6.09% | -3.16% | 0.44% |
RMDFX Aspiriant Defensive Allocation Fund | 2.53% | 18.85% | 1.45% | 8.01% | -6.84% | 4.20% | 5.10% | 11.50% | -4.89% | 8.12% |
Returns By Period
In the year-to-date period, CZAMX achieves a 1.63% return, which is significantly lower than RMDFX's 2.53% return.
CZAMX
- 1D
- 0.11%
- 1M
- -1.68%
- YTD
- 1.63%
- 6M
- 3.67%
- 1Y
- 6.41%
- 3Y*
- 3.81%
- 5Y*
- 2.73%
- 10Y*
- —
RMDFX
- 1D
- 0.25%
- 1M
- -3.79%
- YTD
- 2.53%
- 6M
- 7.56%
- 1Y
- 17.15%
- 3Y*
- 9.46%
- 5Y*
- 5.23%
- 10Y*
- 4.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CZAMX vs. RMDFX - Expense Ratio Comparison
CZAMX has a 1.27% expense ratio, which is higher than RMDFX's 0.18% expense ratio.
Return for Risk
CZAMX vs. RMDFX — Risk / Return Rank
CZAMX
RMDFX
CZAMX vs. RMDFX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Multi-Manager Alternative Strategies Fund (CZAMX) and Aspiriant Defensive Allocation Fund (RMDFX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CZAMX | RMDFX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.66 | 3.47 | -1.81 |
Sortino ratioReturn per unit of downside risk | 2.27 | 4.74 | -2.47 |
Omega ratioGain probability vs. loss probability | 1.31 | 1.75 | -0.45 |
Calmar ratioReturn relative to maximum drawdown | 2.00 | 4.07 | -2.07 |
Martin ratioReturn relative to average drawdown | 5.67 | 17.19 | -11.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CZAMX | RMDFX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.66 | 3.47 | -1.81 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.81 | 0.83 | -0.02 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.79 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.77 | 0.78 | 0.00 |
Correlation
The correlation between CZAMX and RMDFX is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
CZAMX vs. RMDFX - Dividend Comparison
CZAMX's dividend yield for the trailing twelve months is around 3.15%, less than RMDFX's 4.52% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
CZAMX Multi-Manager Alternative Strategies Fund | 3.15% | 3.20% | 2.11% | 2.60% | 7.74% | 1.44% | 0.89% | 2.11% | 1.48% | 0.00% | 0.00% |
RMDFX Aspiriant Defensive Allocation Fund | 4.52% | 4.63% | 0.00% | 3.69% | 0.78% | 5.37% | 2.28% | 3.78% | 4.11% | 2.16% | 1.16% |
Drawdowns
CZAMX vs. RMDFX - Drawdown Comparison
The maximum CZAMX drawdown since its inception was -7.16%, smaller than the maximum RMDFX drawdown of -15.96%. Use the drawdown chart below to compare losses from any high point for CZAMX and RMDFX.
Loading graphics...
Drawdown Indicators
| CZAMX | RMDFX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -7.16% | -15.96% | +8.80% |
Max Drawdown (1Y)Largest decline over 1 year | -2.98% | -4.19% | +1.21% |
Max Drawdown (5Y)Largest decline over 5 years | -5.52% | -14.63% | +9.11% |
Max Drawdown (10Y)Largest decline over 10 years | — | -15.96% | — |
Current DrawdownCurrent decline from peak | -1.68% | -3.79% | +2.11% |
Average DrawdownAverage peak-to-trough decline | -1.57% | -3.37% | +1.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.09% | 0.99% | +0.10% |
Volatility
CZAMX vs. RMDFX - Volatility Comparison
The current volatility for Multi-Manager Alternative Strategies Fund (CZAMX) is 1.00%, while Aspiriant Defensive Allocation Fund (RMDFX) has a volatility of 1.99%. This indicates that CZAMX experiences smaller price fluctuations and is considered to be less risky than RMDFX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CZAMX | RMDFX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.00% | 1.99% | -0.99% |
Volatility (6M)Calculated over the trailing 6-month period | 2.78% | 3.83% | -1.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 3.75% | 5.01% | -1.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 3.37% | 6.34% | -2.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 3.37% | 6.20% | -2.83% |